Aspire Biopharma Inc. (ASBP)
NASDAQ: ASBP
· Real-Time Price · USD
0.55
0.01 (2.38%)
At close: Aug 22, 2025, 3:59 PM
0.51
-6.59%
After-hours: Aug 22, 2025, 07:57 PM EDT
Aspire Biopharma Balance Sheet Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
Cash & Equivalents | 206.23K | 1.35M | 3.63K | 16.54K | 19.6K | n/a | 11.17K | 280.00 | 125.2K |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | 6.67M | 6.6M | 6.52M | 20.14M | 19.9M | 19.64M | 20.02M |
Other Long-Term Assets | n/a | n/a | -6.67M | -6.6M | -6.52M | n/a | -24.87M | n/a | n/a |
Receivables | n/a | n/a | 36.5K | 25.03K | 299.92K | n/a | n/a | n/a | n/a |
Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Assets | n/a | n/a | -36.5K | -25.03K | -299.92K | 65.58K | n/a | 253.08K | 420.94K |
Total Current Assets | 989.42K | 1.97M | 147.99K | 184.04K | 49.6K | 65.58K | 46.17K | 253.36K | 546.14K |
Property-Plant & Equipment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | 5.01M | n/a | 4.97M | n/a | n/a |
Total Long-Term Assets | n/a | n/a | n/a | n/a | 5.01M | 20.14M | n/a | 19.64M | 20.02M |
Total Assets | 989.42K | 1.97M | 147.99K | 184.04K | 5.06M | 20.2M | 46.17K | 19.89M | 20.56M |
Account Payables | 1.35M | 1.43M | 310.22K | 129.39K | 161.53K | n/a | 172.77K | n/a | n/a |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 8.47M | 6.76M | 1.27M | 853.11K | 445.41K | 2M | 360.64K | n/a | n/a |
Other Current Liabilities | n/a | n/a | 111.03K | 3.13K | 157.34K | 633.95K | 626.00 | 316.32K | 284.36K |
Total Current Liabilities | 10.56M | 8.87M | 1.69M | 985.63K | 764.28K | 2.63M | 534.03K | 316.32K | 284.36K |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 49.28K | 49.3K | n/a | n/a | 3.85M | 487.86K | n/a | n/a | n/a |
Total Long-Term Liabilities | 49.28K | 49.3K | n/a | n/a | 3.85M | 487.86K | n/a | n/a | n/a |
Total Liabilities | 10.61M | 8.92M | 1.69M | 985.63K | 4.62M | 2.63M | 534.03K | 316.32K | 284.36K |
Total Debt | 8.47M | 6.76M | 1.27M | 853.11K | 445.41K | 2M | 360.64K | n/a | n/a |
Common Stock | 4.95K | 4.89K | 22K | 221.66K | 221.66K | 20.14M | 221.5K | 19.64M | 20.02M |
Retained Earnings | -20.7M | -18.72M | -2.78M | -2.04M | -1.8M | -13.99M | -1.47M | -10.88M | -10.55M |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | -9.62M | -6.95M | -1.54M | -801.59K | 442.04K | 17.57M | -487.86K | 19.58M | 20.28M |
Total Investments | n/a | n/a | 6.67M | 6.6M | 6.52M | 20.14M | 19.9M | 19.64M | 20.02M |